Vaios, E. J., Batich, K. A., Buckley, A. F., Dunn-Pirio, A., Patel, M. P., Kirkpatrick, J. P., … Peters, K. B. (2022). Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma. Oncotarget, 13, 1165. https://doi.org/10.18632/oncotarget.28292

Vaios, Eugene J., Kristen A. Batich, Anne F. Buckley, Anastasie Dunn-Pirio, Mallika P. Patel, John P. Kirkpatrick, Ranjit Goudar, and Katherine B. Peters. “Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.” Oncotarget 13 (October 20, 2022): 1165. https://doi.org/10.18632/oncotarget.28292.

Vaios EJ, Batich KA, Buckley AF, Dunn-Pirio A, Patel MP, Kirkpatrick JP, et al. Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma. Oncotarget. 2022 Oct 20;13:1165.

Vaios, Eugene J., et al. “Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.” Oncotarget, vol. 13, Oct. 2022, p. 1165. Pubmed, doi:10.18632/oncotarget.28292.

Vaios EJ, Batich KA, Buckley AF, Dunn-Pirio A, Patel MP, Kirkpatrick JP, Goudar R, Peters KB. Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma. Oncotarget. 2022 Oct 20;13:1165.